doi: 10.1161/CIRCHEARTFAILURE.108.819540
Challenges for the Basis of Practice |
Managing Patients with Rapid Atrial Fibrillation and Decompensated Heart Failure
From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Correspondence to Waleed Al-Habeeb, MD, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia. E-mail wal250{at}yahoo.com
Key Words: fibrillation • heart failure
Atrial fibrillation (AF) and heart failure (HF) are 2 global epidemics of cardiovascular disease that often intersect, resulting in significant morbidity and mortality, with a reciprocal causal relationship existing between them.1 AF can exacerbate and, in some cases, cause HF. It has been associated with an adverse prognosis that has been partly attributed to the therapies used.2 It appears that there is no net benefit of a routine strategy to pursue sinus rhythm in patients with AF and chronic HF who have a low left ventricular ejection fraction.3 However, in clinical practice, rate control versus rhythm control for AF in HF represents a dynamic conflict between the neutral results of population trials and the symptomatic deterioration attributed to recurrent AF in selected individuals.
Regardless of the approach to rhythm control for chronic AF in HF, the importance of rate control is unquestioned. This is particularly challenging in the acute setting of HF hospitalization, during which AF is present in one third of patients, regardless of left ventricular ejection fraction.4 Fast rates in AF may exacerbate HF but can also result from dyspnea, anxiety, and hypoperfusion during acute exacerbation of HF with low ejection fraction. The American College of Cardiology/American Heart Association guidelines for the management of chronic HF recommend β-blockers in chronic AF to control heart rate with or without digoxin.5 However, the acute effects of β-blocker titration can include further elevation of filling pressures and depression of stroke volume and blood pressure, diverting a routine admission for diuresis into an intensive care unit admission for intubation and pressors. Calcium channel antagonists are contraindicated in chronic HF as well.6 Digoxin can slow atrioventricular conduction, but the risk of digoxin toxicity may be higher during acute decompensation, with fluctuating renal function and potassium balance.
How should we approach acute control of rapid ventricular response in the patient admitted to the hospital with AF and decompensated HF who has a low left ventricular ejection fraction? It may be necessary to separately consider the 3 situations of (1) new-onset HF with new-onset AF, (2) chronic HF with new-onset AF, and (3) chronic HF with chronic AF and rapid ventricular response in the setting of decompensation.
 |
Disclosures |
|---|
 Top Disclosures References |
|---|
None.
|
Footnotes |
|---|
The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. This is Part I of a 2-part article. Part II appears on page 72.
|
References |
|---|
|
TopDisclosuresReferences |
|---|
1. Efremidis M, Pappas L, Sideris A, Filippatos G. Management of atrial fibrillation in patients with heart failure. J Cardiac Fail. 2008; 14: 232–237.[CrossRef][Medline]
2. Stevenson WG, Stevenson LW. Atrial fibrillation and heart failure: five more years. N Engl J Med. 2004; 351: 2437.
3. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008; 358: 2667–2677.
4. Owan T, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355: 251–259.
5. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2005; 46: e1–e82.
6. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Böhm M. Management of atrial fibrillation in patients with heart failure. Eur Heart J. 2007; 28: 2568–2577.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||